Biliary Atresia Management and Treatment Outcomes

Infants with biliary atresia present with cholestatic jaundice due to progressive fibro-inflammatory obliteration of the extrahepatic bile ducts. Prompt diagnosis and surgical intervention are critical to restore bile flow, preserve hepatic architecture and delay or prevent the need for transplantation. The standard initial therapy is hepatoportoenterostomy, commonly known as the Kasai procedure, ideally performed within the first two months of life. Younger age at surgery correlates with higher rates of bile drainage and improved native liver survival, though outcomes vary considerably among patients. Adjuvant medical therapies, including high-dose corticosteroids, have been explored to modulate postoperative inflammation and enhance cholangiogenesis, with mixed results. Longitudinal follow-up centres on monitoring biochemical markers of cholestasis, imaging of the biliary tree and assessment of growth and neurodevelopment. In many cases, despite successful initial surgery, progressive fibrosis leads to cirrhosis and the eventual necessity for liver transplantation. Recent advances in diagnostic biomarkers and artificial intelligence–driven imaging, along with refinements in perioperative care, aim to individualise management, reduce delays in intervention and improve long-term outcomes for children worldwide.

Research from Nature Portfolio

Seminal work has demonstrated the power of neural-network ensembles in refining diagnostic accuracy for biliary atresia on sonographic gallbladder images. By integrating outputs from multiple deep-learning architectures, these models achieve sensitivity and specificity exceeding 93 per cent, outperforming general radiologists. Importantly, their deployment via smartphone applications extends expert-level interpretation to resource-limited settings and augments clinicians’ performance across experience levels, without compromising transparency of decision-making.

Biliary Atresia Management and Treatment Outcomes publication trend

The graph below shows the total number of articles in biliary atresia management and treatment outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Biliary atresia: Progressive fibro-inflammatory obliteration of the extrahepatic bile ducts causing neonatal cholestasis.

Hepatoportoenterostomy (Kasai procedure): Surgical excision of atretic bile ducts with direct anastomosis of jejunum to the liver hilum to restore bile flow.

Matrix metalloproteinase-7 (MMP-7): A zinc-dependent protease released by biliary epithelium, serving as a serum biomarker to distinguish biliary atresia from other cholestatic disorders.

Ensembled deep learning model: A diagnostic algorithm combining multiple neural networks to enhance accuracy in medical image classification.

References

1. Interpretable artificial intelligence-based app assists inexperienced radiologists in diagnosing biliary atresia from sonographic gallbladder images. BMC Medicine (2024).
2. Serum matrix metalloproteinase-7 for discriminating biliary atresia: a diagnostic accuracy and validation study. Journal of Translational Medicine (2024).
3. Ensembled deep learning model outperforms human experts in diagnosing biliary atresia from sonographic gallbladder images. Nature Communications (2021).
4. Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatric Surgery International (2015).